Research map: ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma

Back to the article

Papers in this map

  1. EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent · Kexin Xu · 2012 · 896 citations · Cited by this paper
  2. Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression · 2026 · Related
  3. Development and function of human innate immune cells in a humanized mouse model · Anthony Rongvaux · 2014 · 795 citations · Cited by this paper
  4. Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies · 2026 · Related
  5. The future of cancer immunotherapy: microenvironment-targeting combinations · Yonina R. Murciano‐Goroff · 2020 · 788 citations · Cited by this paper
  6. Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance · 2026 · Related
  7. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study · Antoîne Italiano · 2018 · 633 citations · Cited by this paper
  8. Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma · 2026 · Related
  9. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications · HP Koeffler · 1983 · 579 citations · Cited by this paper
  10. PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia · 2026 · Related
  11. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas · Faizaan Mohammad · 2017 · 552 citations · Cited by this paper
  12. Mechanistic analysis on epigenetic programming of tumor drug resistance · 2026 · Related
  13. Mammalian Pyrimidine Biosynthesis: Fresh Insights into an Ancient Pathway · David R. Evans · 2004 · 466 citations · Cited by this paper
  14. NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma · 2026 · Related
  15. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies · Yimon Aye · 2014 · 456 citations · Cited by this paper
  16. Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway · 2026 · Related
  17. Zinc finger proteins in cancer progression · Jayu Jen · 2016 · 453 citations · Cited by this paper
  18. Targeting hyaluronan synthesis sensitizes anti-PD1 immunotherapy in cancer · 2026 · Related
  19. Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies · Antonio Passaro · 2022 · 317 citations · Cited by this paper
  20. Immunotherapy in Cancer: Mechanisms and Strategies to Overcome Resistance · 2026 · Related
  21. Humanized Mice for the Study of Immuno-Oncology · Philippe De La Rochère · 2018 · 295 citations · Cited by this paper
  22. A non-proliferative role of pyrimidine metabolism in cancer · Aarif Siddiqui · 2020 · 239 citations · Cited by this paper
  23. ZBED6, a Novel Transcription Factor Derived from a Domesticated DNA Transposon Regulates IGF2 Expression and Muscle Growth · Ellen Markljung · 2009 · 221 citations · Cited by this paper
  24. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells · Yunlong Zhao · 2018 · 196 citations · Cited by this paper
  25. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity · Junli Yan · 2013 · 168 citations · Cited by this paper
  26. EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma · Junli Yan · 2016 · 141 citations · Cited by this paper
  27. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer · Se-Ra Lee · 2015 · 129 citations · Cited by this paper
  28. Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer · not provided You-Tung Wang · 2014 · 119 citations · Cited by this paper
  29. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2) · Guanggai Xia · 2017 · 104 citations · Cited by this paper
  30. The ZBED6–IGF2 axis has a major effect on growth of skeletal muscle and internal organs in placental mammals · Shady Younis · 2018 · 103 citations · Cited by this paper
  31. Thymidine nucleotide metabolism controls human telomere length · William P. Mannherz · 2023 · 82 citations · Cited by this paper
  32. Combinatorial gene control involving E2F and E Box family members · Paloma H. Giangrande · 2004 · 69 citations · Cited by this paper
  33. Risk Factors for Hodgkin's Lymphoma by EBV Status and Significance of Detection of EBV Genomes in Serum of Patients with EBV-Associated Hodgkin's Lymphoma · Ruth F. Jarrett · 2003 · 69 citations · Cited by this paper
  34. Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses · Lei Ren · 2025 · 65 citations · Cited by this paper
  35. Identification of a Human Homologue of the DREF Transcription Factor with a Potential Role in Regulation of the Histone H1 Gene · Nobuko Ohshima · 2003 · 64 citations · Cited by this paper
  36. The importance of the ZBED6‐IGF2 axis for metabolic regulation in mouse myoblast cells · Shady Younis · 2020 · 52 citations · Cited by this paper
  37. Porcine ZBED6 regulates growth of skeletal muscle and internal organs via multiple targets · Dandan Wang · 2021 · 52 citations · Cited by this paper
  38. What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy? · Qingyi Wang · 2021 · 47 citations · Cited by this paper
  39. Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer · Ming‐Shou Hsieh · 2024 · 40 citations · Cited by this paper

Source: OpenAlex (CC0)